Low-power versus high-power laser for holmium laser enucleation of prostate: systematic review and meta-analysis

被引：0
作者：
Liping Chen [1 ]
Changqing Chen [1 ]
Congran Li [1 ]
Zhijia Liu [1 ]
Haixia Qiu [2 ]
Hongwei Bai [1 ]
机构：
[1] Department of Urology, the Eighth Medical Center, Chinese People’s Liberation Army General Hospital, Beijing
[2] Department of Laser Medicine, the First Medical Center, Chinese People’s Liberation Army General Hospital, Beijing
来源：
World Journal of Urology | / 43卷 / 1期
关键词：
Benign prostatic hyperplasia; High-power; HoLEP; Low-power; Meta-analysis;
D O I：
10.1007/s00345-025-05621-5
中图分类号：
学科分类号：
摘要：
Objective: Holmium laser enucleation of the prostate (HoLEP) has emerged as a minimally invasive alternative to transurethral resection of the prostate (TURP), offering benefits such as reduced bleeding and faster recovery. While high-power (HP, 80–100 W) is widely used, low-power (LP, 20–50 W) has gained attention for its cost-effectiveness and versatility. This study presents the first meta-analysis of randomized controlled trials (RCTs) comparing the outcomes of low-power (LP) and high-power (HP) HoLEPin patients with benign prostatic hyperplasia (BPH). Methods: RCTs were retrieved from PubMed, Embase, Web of Science, and the Cochrane Library up to February 28, 2025. Primary outcomes included the International Prostate Symptom Score (IPSS) at three months and intraoperative enucleation efficiency (EE). Secondary outcomes encompassed IPSS, maximum urinary flow rate (Qmax), post-void residual urine volume (PVR), quality of life (QoL) at three and six months, as well as complication incidence and hemoglobin decrease. Statistical analysis was performed using RevMan 5.3. Results: Five studies involving 488 patients (242 in the LP group and 246 in the HP group) were included, with low heterogeneity. LP- and HP-HoLEP demonstrated comparable outcomes in IPSS (MD: 0.45 points, p = 0.35), Qmax (MD: 0.30 mL/s, p = 0.49), PVR (MD: -2.92 mL, p = 0.53), and QoL (MD: 0.16 points, p = 0.46) at three months, with similar results observed at six months. LP-HoLEP showed lower EE (MD: -0.17 g/min, p < 0.00001) but no differences in hemoglobin decrease (MD: 0.00 g/dL, p = 0.95) or complication rates (RR: 0.85, p = 0.37). Conclusions: Although LP-HoLEP may be associated with lower EE, it demonstrates comparable efficacy and safety. Further high-quality studies are necessary to strengthen the evidence base and promote broader clinical adoption of LP-HoLEP. © The Author(s) 2025.
引用
收藏
相关论文
共 23 条
  • [1] Lee S.W.H., Chan E.M.C., Lai Y.K., The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis, Sci Rep, 7, (2017)
  • [2] Gratzke C., Bachmann A., Descazeaud A., Drake M.J., Madersbacher S., Mamoulakis C., Et al., EAU guidelines on the assessment of Non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction, Eur Urol, 67, pp. 1099-1109, (2015)
  • [3] Shvero A., Calio B., Humphreys M.R., Das A.K., HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia, Can J Urol, 28, pp. 6-10, (2021)
  • [4] Li K., Meng C., Li J., Gan L., Peng L., Li Y., Et al., Efficiency and clinical outcomes of Moses technology for holmium laser enucleation of the prostate: an evidence-based analysis, Prostate, 83, pp. 3-15, (2023)
  • [5] Vincent M.W., Gilling P.J., HoLEP has come of age, World J Urol, 33, pp. 487-493, (2015)
  • [6] Elshal A.M., Mekkawy R., Laymon M., Barakat T.S., Elsaadany M.M., El-Assmy A., Et al., Holmium laser enucleation of the prostate for treatment for large-sized benign prostate hyperplasia
  • [7] is it a realistic endourologic alternative in developing country?, World J Urol, 34, pp. 399-405, (2016)
  • [8] Minagawa S., Okada S., Morikawa H., Safety and effectiveness of holmium laser enucleation of the prostate using a Low-power laser, Urology, 110, pp. 51-55, (2017)
  • [9] Pirola G.M., Castellani D., Maggi M., Lim E.J., Chan V.W.S., Naselli A., Et al., Does power setting impact surgical outcomes of holmium laser enucleation of the prostate? A systematic review and meta-analysis, Cent Eur J Urol, 75, pp. 153-161, (2022)
  • [10] Gkolezakis V., Somani B.K., Tokas T., Low- vs. High-Power laser for holmium laser enucleation of prostate, J Clin Med, 12, (2023)
123